NCT03923309View on ClinicalTrials.gov

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Rectal CancerChemoradiation
Trial Locations (3)

13620

Seoul National University Bundang Hospital, Seongnam-si

Unknown

National Cancer Center, Korea, Goyang-si

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

National Cancer Center, Korea

OTHER_GOV

collaborator

Seoul National University Bundang Hospital

OTHER

lead

Seoul National University Hospital

OTHER

NCT03923309 - Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer | Biotech Hunter | Biotech Hunter